sodium metabisulfite has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgemeester, RWK; Schuttelaar, MLA; van Laar, T | 1 |
| Kalaria, DR; Kalia, YN; Merino, V; Patel, P; Patravale, VB | 1 |
2 other study(ies) available for sodium metabisulfite and Parkinson Disease
| Article | Year |
|---|---|
Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases.
Topics: Adult; Aged; Apomorphine; Dopamine Agonists; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Infusions, Subcutaneous; Male; Parkinson Disease; Patch Tests; Preservatives, Pharmaceutical; Sulfites | 2018 |
Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
Topics: Administration, Cutaneous; Animals; Antioxidants; Benzothiazoles; Chromatography, High Pressure Liquid; Ear, External; Electrochemistry; Electroosmosis; Gels; Humans; Iontophoresis; Kinetics; Male; Neurodegenerative Diseases; Parkinson Disease; Pramipexole; Rats; Rats, Wistar; Skin; Sulfites; Swine | 2014 |